Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

58234 Results Found

Public

TLP White Joint Cybersecurity Advisory: Threat Actors Exploiting F5 BIG-IP CVE-2022-1388

The Cybersecurity and Infrastructure Security Agency (CISA) and the Multi-State Information Sharing & Analysis Center (MS-ISAC) are releasing this joint Cybersecurity Advisory (CSA) in response to active exploitation of CVE2022-1388.
Member

H-ISAC TLP White Threat Bulletin: Joint Cybersecurity Advisory – Weak Security Controls and Practices Routinely Exploited for Initial Access

Health-ISAC is distributing the following threat bulletin regarding the observed routine malicious activity of cyber actors exploiting poor security configurations, weak controls, and other poor cyber hygiene practices to gain unauthorized access or as part of other tactics to compromise systems.
Member

H-ISAC Daily Cyber Headlines - May 18, 2022

H-ISAC Daily Cyber Headlines for May 18, 2022.
Member

H-ISAC TLP Green Ransomware Data Leak Sites Report - May 18, 2022

A daily ransomware tracker as TLP:GREEN for purposes of increasing ransomware threat awareness.

ASHRM 2022 Virtual Conference

The ASHRM 2022 Virtual Conference delivers key takeaways from ASHRM 2022 Boston.

Recent Op-Ed Gets it Wrong: Hospital Field Continues to Need Relief and Support

A recent op-ed in the online publication STAT (Turn off the spigot for hospitals’ COVID-19 relief funding) contains blatant factual inaccuracies but also omits critical information about hospital and health systems’ finances and input costs.

AHA blog: Recent op-ed gets it wrong

The hospital field continues to need COVID-19 relief and support, writes AHA’s senior vice president for federal relations, advocacy and political affairs.

Reminder: May 20 deadline to respond to AHA survey on health equity, diversity and inclusion

Hospital and health system leaders focused on health equity and/or diversity and inclusion initiatives in their organizations are encouraged to complete the survey.

FDA authorizes Pfizer booster for children age 5-11; first OTC test for COVID-19, flu and RSV 

FDA today authorized a single booster dose for children 5-11 who completed the Pfizer vaccine primary series at least five months before.